HIV molecular immunology database

 

Search the Epitope Variant and Escape Mutation Database

Results for CTL/CD8+ T-Cell Epitope Variants

Filter results by Mutation Type:

QTGSEELRSLYNTVATLYCVHQRIE Gag(69-93) A2 human epitope
 TGTEELRSLYNTVATLY Gag(70-86) C*14 human epitope
 TGSEELRSLYNTVATLY Gag(70-86) human epitope
 TGSEELRSLYNTVATLY Gag(70-86) human epitope
  GSEELRSLYNTVATL Gag(71-85) human epitope
  GSEELRSLYNTVATL Gag(71-85) human epitope
  GSEELRSLYNTVATLYCVHQ Gag(71-90) human epitope
  GSEELRSLYNTVATLYCVHQ Gag(71-90) human epitope
    EELRSLYNTVATLYC Gag(73-87) A2 human epitope
    EELKSLFNTIAVLWCVHQ Gag(73-90) human epitope
    EELKSLFNTvAVLWCVHk Gag(73-90) observed variant
    EELKSLFNTvAVLWCVHQ Gag(73-90) observed variant
    EELKSLFNTvAVLcCVHQ Gag(73-90) observed variant
    EELKpLFNTvAVLcCVHQ Gag(73-90) observed variant
    EELRSLYNTVATLYCVHQ Gag(73-90) human epitope
     ELRSLYNTVA Gag(74-83) A2 human epitope
     ELKSLYNTVATLYCV Gag(74-88) human epitope
     ELrSLfNTVATLYCV Gag(74-88) subtype-specific susceptible form
     eELrSLYNTVATLYCV Gag(74-88) subtype-specific susceptible form
     ELrSLYNTVATLYCV Gag(74-88) subtype-specific susceptible form
     LKSLfNTVATLYCVH Gag(74-88) subtype-specific susceptible form
       KSLYNTVCV Gag(76-84) H-2Db mouse epitope
       RSLYNTVATLY Gag(76-86) A*02 human epitope
       RSLYNTVATLY Gag(76-86) A*02:01, A*30:02 human epitope
       RSLYNTiATLY Gag(76-86) diminished response; escape documented in this paper
       RSLYNTVAvLY Gag(76-86) diminished response; escape documented in this paper
       RSLYNTiAvLY Gag(76-86) diminished HLA binding or increased off-rate; diminished response; escape documented in this paper
       RSLfNTiATLY Gag(76-86) diminished HLA binding or increased off-rate; diminished response; escape documented in this paper
       RSLfNTVATLY Gag(76-86) diminished HLA binding or increased off-rate; diminished response; escape documented in this paper
       RSLfNTVAvLY Gag(76-86) diminished HLA binding or increased off-rate; diminished response; escape documented in this paper
       RSLfNTiAvLY Gag(76-86) diminished HLA binding or increased off-rate; diminished response; escape documented in this paper
       kSLYNTVATLY Gag(76-86) diminished HLA binding or increased off-rate; diminished response
       kSLYNTVAvLY Gag(76-86) diminished HLA binding or increased off-rate; diminished response; escape documented in this paper
       kSLYNTiATLY Gag(76-86) diminished response; escape documented in this paper
       kSLYNTiAvLY Gag(76-86) diminished HLA binding or increased off-rate; diminished response; escape documented in this paper
       kSLfNTVATLY Gag(76-86) diminished HLA binding or increased off-rate; diminished response; escape documented in this paper
       kSLfNTiATLY Gag(76-86) diminished HLA binding or increased off-rate; diminished response; escape documented in this paper
       kSLfNTVAvLY Gag(76-86) diminished HLA binding or increased off-rate; diminished response; escape documented in this paper
       kSLfNTiAvLY Gag(76-86) diminished HLA binding or increased off-rate; diminished response; escape documented in this paper
       RSLYNTVATLY Gag(76-86) A*29 human epitope
       RSLYNTVATLY Gag(76-86) A*30 human epitope
       RSLYNTVATLY Gag(76-86) A*30 human epitope
       RSLfNTVATLY Gag(76-86) observed variant
       kSLYNTVATLY Gag(76-86) literature escape
       RSLYNTVAvLY Gag(76-86) observed variant
       RSLYNTiATLY Gag(76-86) observed variant
       RSLYNTVvTLY Gag(76-86) observed variant
       RSLYNTVATLY Gag(76-86) A30 human epitope
       RSLYNTVATLY Gag(76-86) A30 human epitope
       RSLYNTVAVLY Gag(76-86) A30 human epitope
       RSLYNTVATLY Gag(76-86) A30 human epitope
       RSLYNTVATLY Gag(76-86) A30 human epitope
       RSLYNTVATLY Gag(76-86) A30 human epitope
       RSLYNTATLY Gag(76-86) A30 human epitope
       RSLYNTVATLY Gag(76-86) A30 epitope
       RSLYNTVATLY Gag(76-86) A30 human epitope
       RSLYNTVATLY Gag(76-86) A*30:02 human epitope
       RSLYNTVATLY Gag(76-86) A*30:02 human epitope
       RLSYNTVATLY Gag(76-86) A*30:02 human epitope
       RSLYNTVATLY Gag(76-86) A*30:02 human epitope
       kSLYNTVATLY Gag(76-86) inferred escape
       kSLYNTVAvLY Gag(76-86) inferred escape
       RSLYNTVATLY Gag(76-86) A*30:02 human epitope
       RSLYNTVATLY Gag(76-86) A*30:02 human epitope
       RSLYNTVATLY Gag(76-86) A*30:02 human, macaque epitope
       RSLYNTVATLc Gag(76-86) escape documented in this paper
       kSLfNTVATLc Gag(76-86) escape documented in this paper
       RSLfNTiATLf Gag(76-86) escape documented in this paper
       RSLYNTVATLY Gag(76-86) A*30:02 human epitope
       RSLYNTVATLY Gag(76-86) A*30:02 human epitope
       RSLYNTVATLY Gag(76-86) A*30:02 human epitope
       RSLYNTVATLY Gag(76-86) A*30:02 human epitope
       RSLYNTVATLY Gag(76-86) B57, B58, B63 human epitope
       RSLYNTVATLY Gag(76-86) B*58 human epitope
       RSLYNTVATLY Gag(76-86) B*63 human epitope
       RSLYNTVATLY Gag(76-86) C*03 human epitope
       RSLFNTVATLY Gag(76-86) human epitope
       RSLyNTVATLY Gag(76-86) observed variant
       RSLYNTVATLY Gag(76-86) human epitope
       KSLYNTVVTLWCVHQ Gag(76-90) human epitope
        SLYNTVATL Gag(77-85) A*02 human epitope
        SLYNTVATL Gag(77-85) A*02 human epitope
        SLYNTVATL Gag(77-85) A*02 human epitope
        SLYNTVATL Gag(77-85) A*02 human epitope
        SLYNTIATL Gag(77-85) A*02 human epitope
        SLYNTVATL Gag(77-85) A*02 human epitope
        SLYNTVATL Gag(77-85) A*02 human epitope
        SLYNTVATL Gag(77-85) A*02 human epitope
        SLFNTVATL Gag(77-85) A*02 human epitope
        SLYNTVATL Gag(77-85) A*02 human epitope
        SLYNTVATL Gag(77-85) A*02 human epitope
        SLYNTVATL Gag(77-85) A*02 human epitope
        SLfNTiAvL Gag(77-85) escape documented in this paper
        SLYNTVATL Gag(77-85) A*02 human epitope
        SLFNTVATL Gag(77-85) A*02 human epitope
        SLYNTVATL Gag(77-85) A*02 human epitope
        SLYNTVATL Gag(77-85) A*02 human epitope
        SLYNTVATL Gag(77-85) A*02 human epitope
        SLYNTVATL Gag(77-85) A*02 human epitope
        SLYNTiATL Gag(77-85) susceptible form
        SLfNTVATL Gag(77-85) susceptible form
        SLfNTVAvL Gag(77-85) susceptible form
        SLfNTiAvL Gag(77-85) susceptible form
        SLhNTVATL Gag(77-85) escape documented in this paper; TCR related mutation
        SLYaaaAaL Gag(77-85) susceptible form
        SLYNTVATL Gag(77-85) A*02 human epitope
        SLYNTVATL Gag(77-85) A*02 human epitope
        SLYNTVAvL Gag(77-85) subtype-specific susceptible form
        SLfNTVATL Gag(77-85) subtype-specific susceptible form
        SLYNTVATL Gag(77-85) A*02 human epitope
        SLYNTVATL Gag(77-85) A*02 human epitope
        SLYNTVATL Gag(77-85) A*02 human epitope
        SLYNTVATL Gag(77-85) A*02 human epitope
        SLYNTVATL Gag(77-85) A*02 human epitope
        SLYNTiATL Gag(77-85) susceptible form
        SLfNTiATL Gag(77-85) diminished response; escape documented in this paper
        SLYNaiATL Gag(77-85) inferred escape
        SLcNTiATL Gag(77-85) inferred escape
        SLYNTVATL Gag(77-85) A*02 human epitope
        SLYNTVATL Gag(77-85) A*02 human epitope
        SLYNTVATL Gag(77-85) A*02 human epitope
        SLYNTVATL Gag(77-85) A*02 human epitope
        SLYNTVATL Gag(77-85) A*02 human epitope
        SLYNTVATL Gag(77-85) A*02 human epitope
        SLYNTVATL Gag(77-85) A*02 human epitope
        SLYNTVATL Gag(77-85) A*02 human epitope
        SLYNTVATL Gag(77-85) A*02 human epitope
        SLYNTVATL Gag(77-85) A*02 human epitope
        SLYNTVATL Gag(77-85) A*02 human epitope
        SLYNTVATL Gag(77-85) A*02 human epitope
        SLYNTVATL Gag(77-85) A*02 human epitope
        SLYNTVATL Gag(77-85) A*02 human epitope
        SLYNTVATL Gag(77-85) A*02 human epitope
        SLYNTVATL Gag(77-85) A*02 human epitope
        SLYNTVATL Gag(77-85) A*02 human epitope
        SLYNTVATL Gag(77-85) A*02 human epitope
        SLYNTVAvL Gag(77-85) HLA association; processing
        SLfNTVATL Gag(77-85) HLA association; processing
        SLYNTiATL Gag(77-85) HLA association; processing
        SLYNTiAvL Gag(77-85) HLA association; processing
        SLfNTiATL Gag(77-85) HLA association; processing
        SLYNTVATL Gag(77-85) A*02 human epitope
        SLfNTVAvL Gag(77-85) diminished response
        SLvNTiATL Gag(77-85) diminished response
        SLYNTVATL Gag(77-85) A*02 human epitope
        SLYNTVATL Gag(77-85) A*02 human epitope
        SLYNTVATL Gag(77-85) A*02 human epitope
        SLYNTVATL Gag(77-85) A*02 human epitope
        SLFNTVATL Gag(77-85) A*02 human epitope
        SLYNTVATL Gag(77-85) A*02 epitope
        SLYNTVATL Gag(77-85) A*02 human epitope
        SLYNTVATL Gag(77-85) A*02 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLfNTVATL Gag(77-85) escape documented in this paper; susceptible form
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLfNaiAvL Gag(77-85) subtype-specific non-susceptible form
        SLfNTVATL Gag(77-85) subtype-specific non-susceptible form
        SLYNTiATL Gag(77-85) subtype-specific susceptible form
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLhNaVAvL Gag(77-85) escape documented in this paper
        SLfNTVATL Gag(77-85) escape documented in this paper
        SLYNTiAvL Gag(77-85) susceptible form
        SLhNTVATL Gag(77-85) escape documented in this paper
        SLlNTVATL Gag(77-85) observed variant
        SLYNTVAvL Gag(77-85) observed variant
        SLYNTiATL Gag(77-85) observed variant
        SLsNTiATL Gag(77-85) observed variant
        SLfNTVAvL Gag(77-85) observed variant
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLFNTVATL Gag(77-85) A*02:01 human epitope
        SLyNTVATL Gag(77-85) subtype-specific non-susceptible form
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 humanized mouse epitope
        SLYNTVATL Gag(77-85) A*02:01 mouse epitope
        SLYNTVATL Gag(77-85) A*02:01 mouse epitope
        SLYNTVATL Gag(77-85) A*02:01 epitope
        SLfNTVATL Gag(77-85) susceptible form
        SLYNTiATL Gag(77-85) susceptible form
        SLYNTVAvL Gag(77-85) susceptible form
        SLYNTVATL Gag(77-85) A*02:01 mouse epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 mouse epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLfNTVATL Gag(77-85) diminished HLA binding or increased off-rate; escape documented in this paper
        SLfNTVAvL Gag(77-85) escape documented in this paper; TCR related mutation
        SLYNTVvTL Gag(77-85) inferred escape
        SLfNTiATL Gag(77-85) inferred escape
        SLYNTiAvL Gag(77-85) escape documented in this paper; TCR related mutation
        SLhNTVAvL Gag(77-85) diminished HLA binding or increased off-rate; escape documented in this paper
        SLYNTVAvL Gag(77-85) diminished HLA binding or increased off-rate; escape documented in this paper
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTiATL Gag(77-85) escape documented in this paper; processing; susceptible form
        SvYNTVATL Gag(77-85) escape documented in this paper; processing; susceptible form
        SLYNlVATL Gag(77-85) escape documented in this paper; processing; susceptible form
        SLfNTVAvL Gag(77-85) escape documented in this paper; processing; susceptible form
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTIATL Gag(77-85) A*02:01 human epitope
        SLYNTIAvL Gag(77-85) susceptible form
        SLYNTvATL Gag(77-85) susceptible form
        SLYNTVATL Gag(77-85) A*02:01 human, transgenic mouse epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 transgenic mouse epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLfNTiATL Gag(77-85) subtype-specific non-susceptible form; subtype-specific susceptible form
        SLYNTVATL Gag(77-85) A*02:01 human, transgenic mouse epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLFNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVAAL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVAvL Gag(77-85) diminished HLA binding or increased off-rate; escape documented in this paper; literature escape; susceptible form
        {k}SLfNTVAvL Gag(77-85) literature escape
        {k}SLfNTiAvL Gag(77-85) literature escape
        {k}SLYNTVATL Gag(77-85) literature escape
        SLfNTVATL Gag(77-85) escape documented in this paper; literature escape; susceptible form
        {k}SLfNTiATL Gag(77-85) literature escape
        {k}SLfNTVATL Gag(77-85) literature escape
        SLYNTiATL Gag(77-85) diminished HLA binding or increased off-rate; diminished response; escape documented in this paper; literature escape; susceptible form
        SLYNTiAvL Gag(77-85) diminished HLA binding or increased off-rate; escape documented in this paper; literature escape; susceptible form
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTiAvL Gag(77-85) literature escape
        SLfNTVATL Gag(77-85) literature escape
        SLYNTiATL Gag(77-85) literature escape
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLfNTVATL Gag(77-85) susceptible form
        SLYNTiATL Gag(77-85) susceptible form
        SLfNTiATL Gag(77-85) susceptible form
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVVTL Gag(77-85) A*02:01 human epitope
        SLYNTVaTL Gag(77-85) susceptible form
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLFNTVATL Gag(77-85) A*02:01 human epitope
        SLFNTVAAL Gag(77-85) diminished response
        SLFNTVATP Gag(77-85) diminished response
        SLFSTVATL Gag(77-85) observed variant
        SLFNTIATL Gag(77-85) susceptible form
        SLYNTVATL Gag(77-85) susceptible form
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLfNTVATL Gag(77-85) subtype-specific susceptible form
        SLYNTiaTL Gag(77-85) subtype-specific susceptible form
        SLYNIiAvL Gag(77-85) subtype-specific susceptible form
        SLYNTVAvL Gag(77-85) subtype-specific susceptible form
        SLfNTiATL Gag(77-85) subtype-specific susceptible form
        SLfNTiAvL Gag(77-85) subtype-specific susceptible form
        SLfNTVAvL Gag(77-85) subtype-specific susceptible form
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 humanized mouse epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        SLfNTVATL Gag(77-85) diminished HLA binding or increased off-rate
        SLYNTVAvL Gag(77-85) diminished HLA binding or increased off-rate
        SLYNTiATL Gag(77-85) diminished HLA binding or increased off-rate
        SLfNTiAvL Gag(77-85) diminished HLA binding or increased off-rate; literature escape
        SLYNTVATL Gag(77-85) A*02:01 human epitope
        {l}SLYNTVAvL Gag(77-85) observed variant
        {l}SLYNTVATL Gag(77-85) susceptible form
        {m}SLYNTVATL Gag(77-85) observed variant
        SLYNaVAvL Gag(77-85) non-susceptible form
        {m}SLYNTVAvL Gag(77-85) observed variant
        {i}SLYNTVATL Gag(77-85) observed variant
        aLYNTVAvL Gag(77-85) observed variant
        aLfNTVATL Gag(77-85) observed variant
        SLYNiVATL Gag(77-85) observed variant
        {q}SLYNTVAvL Gag(77-85) observed variant
        {q}SLYNTVATL Gag(77-85) observed variant
        {v}SLYNTVATL Gag(77-85) observed variant
        SLYNcVATL Gag(77-85) observed variant
        {t}SLYNTVATL Gag(77-85) observed variant
        SLYNTiAsL Gag(77-85) observed variant
        SLYNsVAvL Gag(77-85) observed variant
        SLYNciATL Gag(77-85) observed variant
        aLYNTVATL Gag(77-85) observed variant
        SLYNTVAvL Gag(77-85) observed variant
        SLYNlVATL Gag(77-85) observed variant
        {t}SLYNTVAvL Gag(77-85) observed variant
        {v}SLYNTVAvL Gag(77-85) observed variant
        SLYNTiAvL Gag(77-85) observed variant
        {l}SLYNlVATL Gag(77-85) observed variant
        {n}SLYNTVAvL Gag(77-85) observed variant
        {f}SLYNTVATL Gag(77-85) observed variant
        SLYNTiATL Gag(77-85) observed variant
        SLYNTVAcL Gag(77-85) non-susceptible form
        {l}SLYNTVAcL Gag(77-85) observed variant
        {l}SLYNTVATL{w} Gag(77-85) observed variant
        {c}SLYNTVATL Gag(77-85) observed variant
        {k}SLYNTVATL Gag(77-85) observed variant
        SLYNcVAcL Gag(77-85) non-susceptible form
        SLYNTcAvL Gag(77-85) observed variant
        SLYNTVAsL Gag(77-85) observed variant
        SLfNTVATL Gag(77-85) observed variant
        SLYNlVAvL Gag(77-85) observed variant
        SLYNTVAaL Gag(77-85) observed variant
        {m}SLYNlVATL Gag(77-85) observed variant
        {v}SLYNlVATL Gag(77-85) observed variant
        {h}SLYNTVATL Gag(77-85) observed variant
        {a}SLYNTVATL Gag(77-85) observed variant
        SLYNTVATL{c} Gag(77-85) observed variant
        SLYNTVATL{f} Gag(77-85) observed variant
        {v}SLYNTVATL{w} Gag(77-85) observed variant
        {m}SLYNTVATL{w} Gag(77-85) observed variant
        {w}SLYNTVATL Gag(77-85) observed variant
        {s}SLYNTVATL Gag(77-85) observed variant
        {n}SLYNTVATL Gag(77-85) observed variant
        {a}aLYNTVATL Gag(77-85) observed variant
        {l}aLYNTVATL Gag(77-85) observed variant
        {l}SLYsTVATL Gag(77-85) observed variant
        {c}SLYNTVAvL Gag(77-85) observed variant
        {s}SLYNTVAvL Gag(77-85) observed variant
        {v}SLYNTVAsL Gag(77-85) observed variant
        {l}SLYNTVAaL Gag(77-85) observed variant
        {v}SLYNTVAaL Gag(77-85) observed variant
        SLYNTVAvL{w} Gag(77-85) observed variant
        SLYNTVAvL{s} Gag(77-85) observed variant
        SLYNTVAvL{r} Gag(77-85) observed variant
        SLYNTVATL{w} Gag(77-85) observed variant
        SLYNTVATm Gag(77-85) observed variant
        aLYNTVAaL Gag(77-85) observed variant
        aLYNTVAsL Gag(77-85) observed variant
        SLYNaVATL Gag(77-85) observed variant
        SLYNsVATL Gag(77-85) observed variant
        SLYNvVATL Gag(77-85) observed variant
        SLYNrVATL Gag(77-85) observed variant
        SLYNlVAsL Gag(77-85) observed variant
        SLYNvVAsL Gag(77-85) observed variant
        gLYNTVAvL Gag(77-85) observed variant
        cLYNTVAvL Gag(77-85) observed variant
        gLYNTVATL Gag(77-85) observed variant
        mLYNTVATL Gag(77-85) observed variant
        SLYmTVATL Gag(77-85) observed variant
        SLYrTVATL Gag(77-85) observed variant
        SLYgTVAvL Gag(77-85) observed variant
        SLYsTVAvL Gag(77-85) observed variant
        SLYcTVAvL Gag(77-85) observed variant
        SLYgTVAsL Gag(77-85) observed variant
        SLYgTVgTL Gag(77-85) observed variant
        SLYNTVgTL Gag(77-85) observed variant
        SLYNTVsTL Gag(77-85) observed variant
        SLYNTcATL Gag(77-85) observed variant
        SiYNTVATL Gag(77-85) observed variant
        StYNTVATL Gag(77-85) observed variant
        ScYNTVATL Gag(77-85) observed variant
        SvYNTVATL Gag(77-85) observed variant
        avYNTVATL Gag(77-85) observed variant
        vLYNTVATL Gag(77-85) observed variant
        tLYNTVATL Gag(77-85) observed variant
        rLYNTVATL Gag(77-85) observed variant
        wLYNTVATL Gag(77-85) observed variant
        qLYNTVATL Gag(77-85) observed variant
        SLYyTVATL Gag(77-85) observed variant
        SLYvTVATL Gag(77-85) observed variant
        SLYfTVATL Gag(77-85) observed variant
        SLYsTVATL Gag(77-85) observed variant
        SLYlTVATL Gag(77-85) observed variant
        SLYaTVATL Gag(77-85) observed variant
        SLYtTVATL Gag(77-85) observed variant
        SLYgaVATL Gag(77-85) observed variant
        SLYyTVAvL Gag(77-85) observed variant
        SLYslVATL Gag(77-85) observed variant
        SLYNvlATL Gag(77-85) observed variant
        SLYNTtATL Gag(77-85) observed variant
        SLYNTlATL Gag(77-85) observed variant
        SLYNTVgvL Gag(77-85) observed variant
        SLYNTVAiL Gag(77-85) observed variant
        SLrNTVATL Gag(77-85) observed variant
        SLvNTVATL Gag(77-85) observed variant
        SLwNTVATL Gag(77-85) observed variant
        SLYNTVATv Gag(77-85) observed variant
        SLYNTVATi Gag(77-85) observed variant
        {y}SLYNTVATL Gag(77-85) observed variant
        SLYNTVATL{l} Gag(77-85) observed variant
        {l}SLYNvVATL Gag(77-85) observed variant
        {c}SLYNlVATL Gag(77-85) observed variant
        {c}SLYNvVATL Gag(77-85) observed variant
        {g}SLYNTVATL Gag(77-85) observed variant
        {e}SLYNTVATL Gag(77-85) observed variant
        {l}gLYNTVATL Gag(77-85) observed variant
        SLYNTVAvL{l} Gag(77-85) observed variant
        {k}SvYNTVATL Gag(77-85) observed variant
        {v}gLYNTVATL Gag(77-85) observed variant
        SLYNTVATL{a} Gag(77-85) observed variant
        {v}SLYaTVATL Gag(77-85) observed variant
        SLYgTVATL{m} Gag(77-85) observed variant
        SLYNTVAvL{a} Gag(77-85) observed variant
        SLYgTVATL{a} Gag(77-85) observed variant
        SLYNvVATL{w} Gag(77-85) observed variant
        aLYNTVATL{l} Gag(77-85) observed variant
        SLYNTVAcL{l} Gag(77-85) observed variant
        SLYNTVATL{m} Gag(77-85) observed variant
        {a}SLYNTVAvL Gag(77-85) observed variant
        {v}SLYNTVAcL Gag(77-85) observed variant
        SLYcTVATL Gag(77-85) non-susceptible form
        SLYgTVATL Gag(77-85) observed variant
        SLYhTVATL Gag(77-85) observed variant
        SLYhlVATL Gag(77-85) observed variant
        SLYNmVATL Gag(77-85) observed variant
        SLYNTVvTL Gag(77-85) observed variant
        cLYNTVATL Gag(77-85) observed variant
        {v}SLYNTVATL{l} Gag(77-85) observed variant
        {c}aLYNTVATL Gag(77-85) observed variant
        {q}aLYNTVATL Gag(77-85) observed variant
        {a}SLYNTVATv Gag(77-85) observed variant
        SLYNTVAvL{m} Gag(77-85) observed variant
        {v}SvYNTVATL Gag(77-85) observed variant
        SLYgTVcTL Gag(77-85) observed variant
        SLYNTVATL{r} Gag(77-85) observed variant
        SLYNTVATL Gag(77-85) A*02:01 humanized mouse epitope
        SLYNTVATL Gag(77-85) A*02:01 transgenic mouse epitope
        SLYNTVATL Gag(77-85) A*02:01, A*02:14 human epitope
        SLYNTVATL Gag(77-85) A*02:02 human epitope
        SLYNTVATL Gag(77-85) A*02:02 human epitope
        SLYNTVATL Gag(77-85) A*02:02 human epitope
        SLYNTVATL Gag(77-85) A*02:02, A2 human epitope
        SLfNTVATL Gag(77-85) susceptible form
        SLYNTVATL Gag(77-85) A*02:05 human epitope
        SLYNTVATL Gag(77-85) A2 epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTAVTL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human, transgenic mouse epitope
        SLfNTVATL Gag(77-85) susceptible form
        SLYNlVATL Gag(77-85) susceptible form
        SLfNlVATL Gag(77-85) susceptible form
        SiYNlVATL Gag(77-85) susceptible form
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTiATL Gag(77-85) susceptible form
        SLYNTiAvL Gag(77-85) susceptible form
        SLYNTVAvL Gag(77-85) susceptible form
        SLfNTVATL Gag(77-85) susceptible form
        SLfNTiAvL Gag(77-85) susceptible form
        SLfNTVAvL Gag(77-85) susceptible form
        SLfNTiATL Gag(77-85) susceptible form
        SLYNsVATL Gag(77-85) susceptible form
        SLYqTVATL Gag(77-85) susceptible form
        SLYlTVATL Gag(77-85) susceptible form
        aLYNTVATL Gag(77-85) susceptible form
        SLaNTVATL Gag(77-85) non-susceptible form
        SLYaTVATL Gag(77-85) non-susceptible form
        SLYNTaATL Gag(77-85) diminished response
        SLYNTVAaL Gag(77-85) diminished response
        aLYNTaAaL Gag(77-85) non-susceptible form
        SLYNvVATL Gag(77-85) non-susceptible form
        SLYNlVAvL Gag(77-85) escape documented in this paper; TCR related mutation
        SLYNlVAvL Gag(77-85) escape documented in this paper; TCR related mutation
        SLYNaVATL Gag(77-85) escape documented in this paper; TCR related mutation
        SLYNaiATL Gag(77-85) escape documented in this paper; TCR related mutation
        SLYNlVAvL Gag(77-85) escape documented in this paper; TCR related mutation
        SLYNTVATL Gag(77-85) A2 human, mouse epitope
        SLYNTVAaL Gag(77-85) susceptible form
        lLYNTVATL Gag(77-85) susceptible form
        SLYNTVAsL Gag(77-85) susceptible form
        SLYNTpATL Gag(77-85) susceptible form
        lLYNTVAaL Gag(77-85) susceptible form
        lLYNTVAsL Gag(77-85) susceptible form
        lLYNTVlTL Gag(77-85) susceptible form
        SLYNTsAaL Gag(77-85) susceptible form
        lLYNTpATL Gag(77-85) susceptible form
        SLYNTpAaL Gag(77-85) susceptible form
        SLYNTpAsL Gag(77-85) susceptible form
        SLhNwslaL Gag(77-85) susceptible form
        SLwNwplaL Gag(77-85) susceptible form
        SLwNwplsL Gag(77-85) susceptible form
        SLhNwplaL Gag(77-85) susceptible form
        SLhNwplsL Gag(77-85) susceptible form
        lLwNTslaL Gag(77-85) susceptible form
        lLwNwslaL Gag(77-85) susceptible form
        lLwNwslsL Gag(77-85) susceptible form
        lLwNwplaL Gag(77-85) susceptible form
        lLhNwslaL Gag(77-85) susceptible form
        lLhNwplsL Gag(77-85) susceptible form
        SLfNTVATL Gag(77-85) escape documented in this paper; susceptible form
        SLfNTVAvL Gag(77-85) diminished response; escape documented in this paper
        SLfNTiAvL Gag(77-85) escape documented in this paper; susceptible form
        SLYNTiATL Gag(77-85) diminished response; susceptible form
        SLYNTiAvL Gag(77-85) diminished response; susceptible form
        SvYNTVATL Gag(77-85) diminished response; susceptible form
        SLYNTVAvL Gag(77-85) diminished response; susceptible form
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTiATL Gag(77-85) non-susceptible form; susceptible form
        SLYNTVAvL Gag(77-85) observed variant
        SLfNTVAvL Gag(77-85) escape documented in this paper
        SLfNTVATL Gag(77-85) diminished HLA binding or increased off-rate; susceptible form
        SLfNTiATL Gag(77-85) diminished response
        SLfNTiAvL Gag(77-85) escape documented in this paper; TCR related mutation
        SLhNaVAvL Gag(77-85) susceptible form
        SLYNTiAvL Gag(77-85) diminished response
        SLYNTiAiL Gag(77-85) observed variant
        SLfNTVATv Gag(77-85) susceptible form
        SLYNaVATL Gag(77-85) susceptible form
        SLYNlVAvL Gag(77-85) diminished HLA binding or increased off-rate
        SLYNTVAif Gag(77-85) diminished HLA binding or increased off-rate
        SLfNaVATL Gag(77-85) reversion; susceptible form
        SLfNaVAvL Gag(77-85) susceptible form
        SLfNmVATL Gag(77-85) susceptible form
        SLYNTVsTL Gag(77-85) susceptible form
        SLYNTitvL Gag(77-85) susceptible form
        SLYNTisvL Gag(77-85) susceptible form
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLFNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVAVL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVAvL Gag(77-85) diminished response
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human, transgenic mouse epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLfNTVATL Gag(77-85) observed variant
        SLYNTVAvL Gag(77-85) observed variant
        SLYNTVATi Gag(77-85) observed variant
        SLfNTVATi Gag(77-85) observed variant
        SLnNaiAvL Gag(77-85) observed variant
        SvYNTVATL Gag(77-85) observed variant
        SLFNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 mouse epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLfNTVATL Gag(77-85) escape documented in this paper; susceptible form; TCR related mutation
        SLYNTiATL Gag(77-85) escape documented in this paper
        SLYNTiAvL Gag(77-85) escape documented in this paper; non-susceptible form; susceptible form; TCR related mutation
        SLfNTiATL Gag(77-85) escape documented in this paper; non-susceptible form; susceptible form; TCR related mutation
        SLYNlVAvL Gag(77-85) escape documented in this paper; non-susceptible form; TCR related mutation
        SLYNTVAaL Gag(77-85) observed variant
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLfNTVATL Gag(77-85) escape documented in this paper
        SLYNTVAvL Gag(77-85) escape documented in this paper
        SLYNTVATL Gag(77-85) A2 transgenic mouse epitope
        SLYNTVATL Gag(77-85) A2 humanized mouse epitope
        SLYNTVATL Gag(77-85) A2 epitope
        SLFNTVATL Gag(77-85) A2 human epitope
        SLYNTIATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 transgenic mouse epitope
        SLFNTVATL Gag(77-85) A2 human epitope
        SLyNTVATL Gag(77-85) susceptible form
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLfNTVATL Gag(77-85) susceptible form
        SLYNTiATL Gag(77-85) susceptible form
        SLYNTVAvL Gag(77-85) susceptible form
        SLYNaVATL Gag(77-85) susceptible form
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLfNTVATL Gag(77-85) subtype-specific susceptible form
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLfNTVATL Gag(77-85) observed variant
        SLfNTVAvL Gag(77-85) diminished HLA binding or increased off-rate
        SLsNTVATL Gag(77-85) diminished HLA binding or increased off-rate
        SsfNTVATL Gag(77-85) observed variant
        SLlNTVATL Gag(77-85) diminished HLA binding or increased off-rate
        SLcNTVATL Gag(77-85) diminished HLA binding or increased off-rate
        SLYNTiATL Gag(77-85) observed variant
        SLfNaVATL Gag(77-85) diminished HLA binding or increased off-rate
        SLfNTiAvL Gag(77-85) diminished HLA binding or increased off-rate
        SLfNTiATL Gag(77-85) observed variant
        SLYNTiAvL Gag(77-85) diminished HLA binding or increased off-rate
        SLYNTVATL Gag(77-85) A2 human epitope
        SLfNTVATL Gag(77-85) observed variant
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVAvL Gag(77-85) susceptible form
        SLfNTVAvL Gag(77-85) susceptible form
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLfNTVcvi Gag(77-85) diminished response; escape documented in this paper; subtype-specific non-susceptible form; TCR related mutation
        SLfNTVATL Gag(77-85) diminished response; escape documented in this paper; subtype-specific non-susceptible form; TCR related mutation
        SLfNaVATL Gag(77-85) diminished response; escape documented in this paper; subtype-specific non-susceptible form; TCR related mutation
        SLaNTVATL Gag(77-85) diminished response; escape documented in this paper; TCR related mutation
        SLYaTVATL Gag(77-85) diminished response; escape documented in this paper; TCR related mutation
        SLYNaVATL Gag(77-85) diminished response; escape documented in this paper; TCR related mutation
        SLYNTaATL Gag(77-85) susceptible form
        SLYNTVAaL Gag(77-85) diminished response; escape documented in this paper; TCR related mutation
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLFNTVATL Gag(77-85) A2 human epitope
        SLyNTVATL Gag(77-85) escape documented in this paper
        SLyNaVATL Gag(77-85) escape documented in this paper
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 transgenic mouse epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLfNTVATL Gag(77-85) observed variant
        SLYNTiATL Gag(77-85) observed variant
        SLYNTVATL Gag(77-85) A2 human epitope
        SLfNTiATL Gag(77-85) escape documented in this paper
        SLfNTiAaL Gag(77-85) observed variant
        SLfNTVAvL Gag(77-85) escape documented in this paper
        SLfsTVAvL Gag(77-85) observed variant
        SLfNTVAvp Gag(77-85) observed variant
        SLfNTiAvL Gag(77-85) observed variant
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2 human epitope
        SLYNTVATL Gag(77-85) A2, A68 human epitope
        SLfNTiATL Gag(77-85) diminished response
        SLYNTVATL Gag(77-85) B*57 human epitope
        SLYNTVATL Gag(77-85) C*14 human epitope
        SLYNTVATL Gag(77-85) H-2d human, mouse epitope
        SLYNTVATL Gag(77-85) human epitope
        SLYNTVATL Gag(77-85) human epitope
        SLYNTVATL Gag(77-85) human epitope
        SLYNTVATL Gag(77-85) human epitope
        SLFNTVATL Gag(77-85) human epitope
        SLYNTVATL Gag(77-85) human epitope
        SLYNTVATL Gag(77-85) human epitope
        SLYNTVATL Gag(77-85) human epitope
        SLYNTVATL Gag(77-85) human epitope
        SLYNTVATL Gag(77-85) human epitope
        SLYNTVATL Gag(77-85) human epitope
        SLYNTVATL Gag(77-85) human epitope
        pLYNTVATL Gag(77-85) HLA association; TCR related mutation
        SLfNTVATL Gag(77-85) HLA association; TCR related mutation
        SLYNTiATL Gag(77-85) HLA association; TCR related mutation
        SLfNTVAvL Gag(77-85) HLA association; TCR related mutation
        SLfNaVAvL Gag(77-85) HLA association; TCR related mutation
        SLYNTVATL Gag(77-85) human epitope
        SLYNTVATL Gag(77-85) human epitope
        SLYNTVATL Gag(77-85) human epitope
        SLYNTVATL Gag(77-85) human epitope
        SLYNTVATL Gag(77-85) epitope
        SLYNTVAvL Gag(77-85) susceptible form
        SLYNTiATL Gag(77-85) escape documented in this paper; susceptible form
        SLYNTiAvL Gag(77-85) susceptible form
        SLYNTVATL Gag(77-85) human epitope
        SLYNTVATL Gag(77-85) human epitope
        SLYNTVATL Gag(77-85) human epitope
        SLYNTVATLY Gag(77-86) A*02 human epitope
        SLYNTVAvLY Gag(77-86) diminished HLA binding or increased off-rate; escape documented in this paper; susceptible form
        SLYNTiATLY Gag(77-86) diminished HLA binding or increased off-rate; escape documented in this paper; susceptible form
        SLYNTiAvLY Gag(77-86) diminished HLA binding or increased off-rate; escape documented in this paper; susceptible form
        SLfNTVATLY Gag(77-86) diminished HLA binding or increased off-rate; escape documented in this paper; susceptible form
        SLfNTiAvLY Gag(77-86) diminished HLA binding or increased off-rate; escape documented in this paper; susceptible form
        SLfNTVAvLY Gag(77-86) diminished HLA binding or increased off-rate; escape documented in this paper; susceptible form
        SLfNTiATLY Gag(77-86) diminished HLA binding or increased off-rate; escape documented in this paper; susceptible form
        SLYNTVATLY Gag(77-86) A*02 human epitope
        SLYNTVATLY Gag(77-86) A*02:01 human epitope
        SLYNTVATLY Gag(77-86) A2 human epitope
        SLYNTVATLY Gag(77-86) A2 human epitope
        SLYNTVATLY Gag(77-86) human epitope
        SLYNTVATLY Gag(77-86) human epitope
        SLFNTVATLY Gag(77-86) human epitope
        SLYNIVATLWCVH Gag(77-89) human epitope
        SLYNTVATLYCVHQR Gag(77-91) A*02:01, A*30:02 human epitope
        SLfNTVATLYCVHQR Gag(77-91) susceptible form
        SLYNTVATLYCVHQR Gag(77-91) A2, B44, B60 human epitope
        SLYNTVATLYCVHQR Gag(77-91) H-2d transgenic mouse epitope
        SLYNTVATLYCVHQR Gag(77-91) human epitope
        SLYNTVATLYCVHQR Gag(77-91) mouse epitope
        SLYNTVATLYCVHQRIEV Gag(77-94) human epitope
        SLYNTVATLYCVHQRIEV Gag(77-94) human epitope
         LYNTVATL Gag(78-85) A*02 human epitope
         LYNTVATL Gag(78-85) A24 human epitope
         LYNTVATL Gag(78-85) C*14 human epitope
         LYNTVATL Gag(78-85) C*14 human epitope
         LYNTVATL Gag(78-85) C*14 human epitope
         LYNTVATL Gag(78-85) C*14 human epitope
         LYNTVAVL Gag(78-85) C*14 human epitope
         LYNTVATL Gag(78-85) C*14:02 human epitope
         LYNTVATL Gag(78-85) C*14:02, C*14:03 human epitope
         LYNTVATL Gag(78-85) H-2d mouse epitope
         LYNTVATL Gag(78-85) human epitope
         LYNTVATLY Gag(78-86) A*02 human epitope
         LYNTVAVLY Gag(78-86) A*29 human epitope
         LYNTiAVLY Gag(78-86) observed variant
         LfNTiAVLY Gag(78-86) observed variant
         LfNTVAVLY Gag(78-86) observed variant
         LYNTVATLY Gag(78-86) A*29 human epitope
         LYNTVATLY Gag(78-86) A*29 human epitope
         LYNTVATLY Gag(78-86) A*29 human epitope
         LYNTVATLY Gag(78-86) A*29, B*44 epitope
         LYNTVATLY Gag(78-86) A29 human epitope
         LYNTIATLY Gag(78-86) A*29:02 human epitope
         LYNTVATLY Gag(78-86) A*29:02 human epitope
         LYNTVATLY Gag(78-86) A*29:02 human epitope
         LFNTVATLY Gag(78-86) A*29:02 human epitope
         LYNTVATLY Gag(78-86) A*29:02, B*44:03 human epitope
         LYNTVATLY Gag(78-86) A*29:02, B*44:03 human epitope
         LYNTVATLY Gag(78-86) A*30 human epitope
         LYNTVATLY Gag(78-86) B*44:03 human epitope
         LYNTVATLY Gag(78-86) B*81 human epitope
         LYNTVATLY Gag(78-86) C*14 human epitope
         LYNTVATLY Gag(78-86) human epitope
         LFNTVATLY Gag(78-86) human epitope
         LyNTVATLY Gag(78-86) observed variant
         LYNTVATLY Gag(78-86) human epitope
         LYNTVATLY Gag(78-86) human epitope
         LFNTVATLYCV Gag(78-88) A*02 human epitope
         LYNTVATLYCVHQRI Gag(78-92) human epitope
          YNIVATLWCVHQ Gag(79-90) human epitope
          YNtVATLWCVHQ Gag(79-90) subtype-specific susceptible form
          YNTVATLYCVHQRI Gag(79-92) human epitope
           NTVATLYCV Gag(80-88) A2 human, transgenic mouse epitope
           NTVATLYCV Gag(80-88) A2 human epitope
           NTVATLYCV Gag(80-88) A2 human epitope
           NaiAvLYCV Gag(80-88) observed variant
           NTVAvLYCV Gag(80-88) observed variant
           NTVATiYCV Gag(80-88) observed variant
           NTVATLYCV Gag(80-88) observed variant
            TVATLYCVH Gag(81-89) C*12:02 human epitope
            TVATLYCVH Gag(81-89) human epitope
            TVATLYCVHQRIEVK Gag(81-95) mouse epitope
            TVATLYCVHQRIEVKDTKEA Gag(81-100) human epitope
             VATLYCVHQ Gag(82-90) human epitope
             IATLWCVHQR Gag(82-91) A*11 human epitope
             IAVLYCVHQR Gag(82-91) A*11 epitope
             IvVLYCVHQR Gag(82-91) observed variant
             IATLWCVHQR Gag(82-91) A11 human epitope
             IATLWCVHQR Gag(82-91) human epitope
             VATLYCVHQRI Gag(82-92) A*11 human epitope
             VvTLYCVHQRI Gag(82-92) susceptible form
             VATLYCVHQRIEVK Gag(82-95) human epitope
              ATLYCVHQR Gag(83-91) A*11 human epitope
              AVLYCVHQR Gag(83-91) A11 human epitope
              ATLYCVHQR Gag(83-91) A*11:01 human epitope
              ATLYCVHQK Gag(83-91) human epitope
              ATLYCVHQK Gag(83-91) human epitope
              ATLYCVHQK Gag(83-91) human epitope
              ATLYCVHQR Gag(83-91) human epitope
              {A}TLYCVHQK{IE} Gag(83-93) A*11 human epitope
              ATLWCVHQRIDI Gag(83-94) human epitope
              ATLWCVHQRIev Gag(83-94) subtype-specific susceptible form
              ATLYCVHEKIEVRDTKEALDK Gag(83-103) human epitope
               TLYCVHQK Gag(84-91) A*11 human epitope
               TLYCVHQR Gag(84-91) A11 human epitope
               TLYCVHQk Gag(84-91) susceptible form
               TLYCVHQq Gag(84-91) diminished response
               TLYCVHeR Gag(84-91) escape documented in this paper
               TLYCVHQR Gag(84-91) A*11:01 human epitope
               TLYCVHQk Gag(84-91) susceptible form
               TLwCVHQR Gag(84-91) observed variant
               TLYCVHeR Gag(84-91) observed variant
               TLYCVHQK Gag(84-91) A*11:01 human epitope
               VLYCVHQG Gag(84-91) A*11:01 human epitope
               TMYCVHQK Gag(84-91) A*11:01 human epitope
               TlYCVHQr Gag(84-91) diminished response; escape documented in this paper; non-susceptible form
               vlYCVHQr Gag(84-91) diminished response; escape documented in this paper; non-susceptible form
               TlYCVHQK Gag(84-91) diminished response; escape documented in this paper; non-susceptible form; susceptible form
               TLYCVHQK Gag(84-91) human epitope
               TLYCVHQK Gag(84-91) human epitope
               TLYCVHQRI Gag(84-92) A*11 epitope
               TLYCVHQRI Gag(84-92) A*11 human epitope
               TLYCVHQRI Gag(84-92) A*11 human epitope
               TLYCVHQRI Gag(84-92) A11 human epitope
               TLYCVHQRI Gag(84-92) A11 human epitope
               TLYCVHQRI Gag(84-92) A11 human epitope
               TLYCVHQRI Gag(84-92) A11 human epitope
               TLYCVHQRI Gag(84-92) A11 human epitope
               TLYCVHQRI Gag(84-92) A11 human epitope
               TLYCVHQRI Gag(84-92) A11 human epitope
               TLYCVHQKI Gag(84-92) A*11:03 human epitope
               VLYCVHQRI Gag(84-92) A2 human epitope
               TLYCVHQRI Gag(84-92) A*32 human epitope
               TLYCVHQRI Gag(84-92) B*13 human epitope
               TLYCVHQRI Gag(84-92) C*12 human epitope
                LYCVHQKI Gag(85-92) A24 human epitope
                LYCVHQRI Gag(85-92) H-2d mouse epitope
                 YCVHAGIEVRD Gag(86-96) human epitope
                 YCVHQRIEIKDTKEAL Gag(86-101) human epitope
                 YCVHQRIEIKDTKEAL Gag(86-101) human epitope
                  CVHQRIEVK Gag(87-95) A*02 human epitope
                  CVHQRIEVK Gag(87-95) A*03:01 human epitope
                  CVHQRIEIK Gag(87-95) A11 human epitope
                  CRIDVKDTKEALEKIE Gag(87-105) human epitope
                   VHQRIEIKDTKEALDKIEEEQNKSKKKA Gag(88-115) A2 human epitope
                   VHQRIEIKDTKEALDKIEEEQNKSKKKA Gag(88-115) H-2d mouse epitope
                    HQRIEIKDTK Gag(89-98) A11 human epitope
                      RIDVKDTKEAL Gag(91-101) human epitope
                      RIDVKDTKEALEKIE Gag(91-105) human epitope
                       IEIKDTKEAL Gag(92-101) A*01 human epitope
                       IEIKDTKEAL Gag(92-101) A*29 human epitope
                       IEIKDTKEAL Gag(92-101) B*08 human epitope
                       IEIKDTKEAL Gag(92-101) B*35:02, B*35:03, B*53:01 human epitope
                       IEIKDTKEAL Gag(92-101) B*40 human epitope
                       IEIKDTKEAL Gag(92-101) B*40 human epitope
                       {K}IEIKDTKEAL Gag(92-101) B*40 human epitope
                       IEIKDTKEAL Gag(92-101) B40 human epitope
                       IEIKDTKEAL Gag(92-101) B40 human epitope
                       IEIKDTKEAL Gag(92-101) B40 human epitope
                       IEIKDTKEAL Gag(92-101) B40 human epitope
                       IEIKDTKEAL Gag(92-101) B*40:01 human epitope
                       IEIKDTKEAL Gag(92-101) B*40:01 human epitope
                       VEIKDTKEAL Gag(92-101) B*40:01 human epitope
                       IDIKDTKEAL Gag(92-101) B*40:01 human epitope
                       IEIKDTKEAL Gag(92-101) B*42:01 human epitope
                       IEIKDTKEAL Gag(92-101) B*60, B*61 human epitope
                       IEIKDTKEAL Gag(92-101) B60 human epitope
                       IEIKDTKEAL Gag(92-101) B60 human epitope
                       IEIKDTKEAL Gag(92-101) B60 human epitope
                       IEIKDTKEAL Gag(92-101) B60 human epitope
                       IEIKDTKEAL Gag(92-101) B60 human epitope
                       IEIKDTKEAL Gag(92-101) B60 human epitope
                       IEIKDTKEAL Gag(92-101) B60 human epitope
                       IEIKDTKEAL Gag(92-101) B60 human epitope
                       IEVKDTKEAL Gag(92-101) human epitope
                       IEVKDTrEAL Gag(92-101) observed variant
                       IgVKDTKEAL Gag(92-101) observed variant
                       IEiKDTKEAL Gag(92-101) observed variant
                       IEVKDTKEAv Gag(92-101) observed variant
                       {HQr}IEVKDTKEAv{DKLEE} Gag(92-101) observed variant
                       {HQr}IgVKDTKEAL{DKLEE} Gag(92-101) observed variant
                       {HQr}IaVKDTKEAL{DKLEE} Gag(92-101) observed variant
                       {HQr}IEVKDTKEAL{DKLEE} Gag(92-101) observed variant
                       IEIKDTKEAL Gag(92-101) human epitope
                       IEIKDTKEAL Gag(92-101) human epitope
                       IEIKDTKEAL Gag(92-101) human epitope
                        EVKDTKEAL Gag(93-101) B*08 human epitope
                        dVKDTKEAL Gag(93-101) diminished response
                        EiKDTKEAL Gag(93-101) inferred escape
                        kVKDTKEAL Gag(93-101) inferred escape
                        EVKDTKgAL Gag(93-101) inferred escape
                        EIKDTKEAL Gag(93-101) B*08 human epitope
                        EvKDTKEAL Gag(93-101) susceptible form
                        dvKDTKEAL Gag(93-101) susceptible form
                        EIKDTKEAL Gag(93-101) B*08, B*60 human epitope
                        DVKDTKEAL Gag(93-101) B*08:01 human epitope
                        DVKDTKEAL Gag(93-101) B*08:01 human epitope
                        DIKDTKEAL Gag(93-101) B*08:01 human epitope
                        EVKDTKEAL Gag(93-101) B*08:01 human epitope
                        dVKgTKEAL Gag(93-101) escape documented in this paper
                        dVKDTKEAL Gag(93-101) escape documented in this paper; susceptible form
                        EVKDTKEAL Gag(93-101) B*08:01 human epitope
                        EIKDTKEAL Gag(93-101) B*08:01 human epitope
                        EIKDTKEAL Gag(93-101) B60, B8 human epitope
                        EIKDTKEAL Gag(93-101) B8 human epitope
                        EIKDTKEAL Gag(93-101) B8 human epitope
                        EIKDTKEAL Gag(93-101) B8 human epitope
                        EIKDTKEAL Gag(93-101) B8 human epitope
                        EvKDTKEAL Gag(93-101) observed variant
                        dvKDTKEAL Gag(93-101) observed variant
                        EIlDTKEAL Gag(93-101) observed variant
                        dIKDTKEAL Gag(93-101) reversion
                        DVKDTKEAL Gag(93-101) human epitope
                        EVKDTKEAL Gag(93-101) human epitope
Questions or comments? Contact us at immuno@lanl.gov
 
Managed by Triad National Security, LLC for the U.S. Department of Energy’s National Nuclear Security Administration
Copyright © 2022 Triad National Security, LLC | Disclaimer/Privacy

Dept of Health & Human Services Los Alamos National Institutes of Health